アテレクトミー装置の市場レポート：製品用途、エンドユーザー、地域別、2024～2032年

アテレクトミー装置の市場の世界市場規模は、2023年に9億7,800万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに14億7,600万米ドルに達し、2024～2032年の間に4.5％の成長率（CAGR）を示すと予測しています。末梢動脈疾患（PAD）の増加、大幅な技術発展、高齢化人口の増加、低侵襲手術の登場、医療インフラの開拓、新興経済諸国における償還政策などが、粥腫アテレクトミー術市場の成長を促進する主要要因となっています。

アテレクトミー装置の市場分析：

主要市場促進要因：アテレクトミー装置の市場は、末梢動脈疾患（PAD）やその他の心血管疾患の症例増加の影響を受けています。糖尿病、肥満、喫煙の増加とともに、これらの病気にかかりやすい高齢化人口の増加が、これらの機器に対する間接的な需要を生み出しています。さらに、アテレクトミー手術の技術的進歩や低侵襲手術の人気の高まりが、市場に大きな機会をもたらしています。

主要市場動向：アテレクトミー装置の市場は、PAD症例の増加や低侵襲手術の必要性といった重要な動向によって拡大しています。技術の進歩により、より高度な装置の製造が可能になり、その結果、精度が向上し、回復期間が短縮されます。方向性アテレクトミーシステムも、血管壁を傷つけることなくアテローム性動脈硬化プラークを狙い撃ちして除去できるため、人気が高まっています。新興国では、医療インフラの成長と償還状況の改善が、アテレクトミー装置の入手と使用を世界的に促進しています。

競合情勢：アテレクトミー装置業界の主要市場参入企業には、Abbott Laboratories、Avinger、B. Braun Melsungen AG、Biomerics、Biotronik、Boston Scientific Corporation、C.R. Bard（Becton, Dickinson and Company）、Cardinal Health、Koninklijke Philips N.V.、Medtronic、Minnetronix Inc.、Straub Medical AG（Becton, Dickinson and Company）、Terumo Corporationなどがあります。

課題と機会：アテレクトミー装置の市場は、高い医療機器コストや製品上市の遅れの原因となる厳しい規制要件など、いくつかの課題に悩まされています。その一方で、市場機会は末梢動脈疾患の罹患率の増加や高齢化によって影響を受けています。機器の性能と安全性を向上させる技術の開発が成長機会をもたらします。さらに、新興市場における医療インフラの成長は市場拡大の新たな前線を生み出し、アテレクトミー手術の世界の需要を刺激しています。

アテレクトミー装置の市場動向：

末梢動脈疾患（PAD）患者の増加

高齢化、糖尿病や肥満の増加により、世界レベルでPADの症例が増加しており、アテレクトミー装置市場の成長を牽引しています。米国では約800万人から1,200万人がPADに罹患しており、特に50歳以上の患者が多いです。このうち40歳以上の650万人がPADと診断されています。アテレクトミーは血管インターベンションの重要な選択肢であり、動脈プラークを除去する低侵襲的アプローチを記載しています。この装置は血流を促進し、脚の痛みや疲労などの症状を軽減します。プラークを直接切断または蒸発させることにより、これらの器具は動脈開存性を回復させ、重症のPAD患者の転帰を著しく改善します。

技術の進歩

アテレクトミー装置の主要技術革新には、方向制御装置や高周波回転技術の登場が含まれ、これらはこれらの装置の有効性と安全性を改善し続けています。例えば、2020年の研究によると、プラークを砂状にする軌道アテレクトミーは90％の確率で閉塞した下肢動脈を効果的に開通させ、レーザーアテレクトミーも同様に76％の確率で血流の改善を達成しています。このような患者の治療成績の改善と外科医の嗜好が、アテレクトミー装置の成長を後押ししています。172人の患者を対象とした多施設共同研究において、ジェットストリームの使用は99％の成功率を示し、6ヵ月と12ヵ月の臨床的な標的病変の再灌流率はそれぞれ15％と26％でした。

新興市場への進出

著名な主要参入企業は、医療インフラ整備と新興経済諸国への医療費支出増が注目される新興国市場に注力しており、それによって市場の主要参入企業に新たな機会がもたらされています。例えば、ブラジル、ロシア、インド、中国、南アフリカ（BRICS）の新興市場は、世界の医療セグメントにおける医療品とサービスの需要と供給の状況をますます形成しつつあります。2030年のGDPに占める医療支出の割合は、ブラジル8.4％、ロシア5.2％、インド3.5％、中国5.9％、南アフリカ10.4％と予測されています。これらの市場への浸透は、より高度な治療選択肢の実現によって可能となり、アテレクトミー装置の世界の普及を拡大します。

アテレクトミー装置の市場セグメンテーション：

IMARC Groupでは、2024～2032年の世界、地域、国レベルの予測とともに、市場の各セグメントにおける主要動向の分析を提供しています。製品別、用途別、エンドユーザー別に市場を分類しています。

製品別の内訳

方向性アテレクトミー装置が市場シェアの大半を占める

本レポートでは、製品別に市場を詳細に区分・分析しています。これには、指向性アテレクトミー装置、軌道アテレクトミー装置、光アテレクトミーアテレクトミー装置、回転アテレクトミー装置、サポート装置が含まれます。同レポートによると、方向性粥腫アテレクトミー装置が最大のセグメントを占めています。

方向性アテレクトミー器具は、閉塞動脈からアテローム性動脈硬化プラークを正確に除去するために開発されました。これらの器具は正確な制御の可能性を提供し、患者の安全性と回復にとって重要な点である血管壁の外傷を軽減します。複数の血管サイズの複雑な病変を治療する能力があるため、血管専門医に好まれ、この製品セグメントの成長につながりました。手技中にプラークを回収・除去できることが、これらの器具を際立たせ、多くの臨床場面で好まれています。

用途別内訳

末梢血管が市場シェアの大半を占める

本レポートでは、市場を用途別に詳細に区分・分析しています。これには、末梢血管、心血管、神経血管が含まれます。報告書によると、末梢血管が最大のセグメントを占めています。

PADの有病率が高まっているため、末梢血管疾患の治療におけるアテレクトミー装置の使用は重要です。このような器具は下肢動脈の血流を再確立する上で重要な役割を果たし、痛みや運動障害などの症状を緩和するのに役立ちます。このセグメントの需要は、従来の手術に比べて回復期間が短く、合併症のリスクが低いため、患者の転帰や治療効率が高くなる低侵襲手術の特徴によって決定されます。

エンドユーザー別内訳

病院が市場シェアの大半を占める

本レポートでは、エンドユーザー別に市場を詳細に区分・分析しています。これには、病院、外来手術センター、研究所・学術機関が含まれます。報告書によると、病院が最大のセグメントを占めています。

これらの処置は非常に複雑であり、高度なインフラと高度な訓練を受けた医療専門家が必要であるため、病院はアテレクトミー装置の主要ユーザーです。このセグメントの成長は、病院で行われる血管手術の件数の増加に続いており、先端技術への投資や医療従事者のトレーニングプログラムへの投資がその原動力となっています。また、病院が術後の必要条件を含むあらゆる種類のケアを提供できることも、市場を独占する要因となっています。

地域別内訳

北米が市場を独占

この調査レポートは、北米（米国、カナダ）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、インドネシア、その他）、欧州（ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他）、ラテンアメリカ（ブラジル、メキシコ、その他）、中東アフリカを含むすべての主要市場の包括的な分析も掲載しています。報告書によると、アテレクトミー装置の最大市場は北米です。

北米がアテレクトミーの最大市場であるのは、心血管疾患の有病率が高いこと、医療制度が発展していること、同地域の主要な市場参入企業が存在することによる。米国がこの地域で最大の市場であるのは、有利な償還シナリオ、臨床試験、先端医療機器の研究開発に対する政府の堅実な支援によるものです。同地域の新しい医療ソリューションの応用への取り組みが、市場成長の原動力となっています。

競合情勢：

市場調査レポートは、市場の競合情勢についても包括的に分析しています。すべての主要企業の詳細プロファイルが提供されています。アテレクトミー装置の市場の主要な市場参入企業には、Abbott Laboratories、Avinger、B. Braun Melsungen AG、Biomerics、Biotronik、Boston Scientific Corporation、C.R. Bard（Becton, Dickinson and Company）、Cardinal Health、Koninklijke Philips N.V.、Medtronic、Minnetronix Inc.、Straub Medical AG（Becton, Dickinson and Company）、Terumo Corporationなどがあります。

（これは主要参入企業の一部であり、完全なリストは報告書に記載されていることに留意されたい）。

アテレクトミーの市場はダイナミックであり、市場シェアを拡大し、低侵襲手術に対する需要の高まりに対応するため、大手企業は進化する戦略を駆使しています。これらのアプローチの1つは技術志向であり、つまり各社は研究開発に多大な投資を行い、より効率的で安全な機器を改良しています。もうひとつは、戦略的提携や協力関係で、知識の共有や流通チャネルの改善を支援するものです。さらに、合併や買収も一般的で、これによって企業は製品ポートフォリオを拡大し、地理的範囲を広げることができます。多くの市場において、企業は製品の効率性と安全性を保証する厳しい基準を満たそうとしているため、規制機関による承認が重要な役割を果たしています。

アテレクトミー装置の市場ニュース

2022年3月、B. Braunは透析用濃縮製剤のスペシャリストであるIntermedt Medizin & Technik GmbHを買収しました。

2023年11月、Cardinal Healthは、手術室での安全で便利な器具アクセスを外科チームに提供するために開発された、アシスト器具ポケット付きSmartGown EDGE通気性手術衣の米国での発売を発表しました。

本レポートの主要質問

• 2023年におけるアテレクトミー装置の市場の世界市場規模は？
• 2024～2032年におけるアテレクトミー装置の市場の世界市場成長率は？
• 世界のアテレクトミー装置の市場に対するCOVID-19の影響は？
• 世界のアテレクトミー装置の市場を牽引する主要要因は何か
• アテレクトミー装置の市場の製品別内訳は？
• 世界のアテレクトミー装置の市場の用途別内訳は？
• 世界のアテレクトミー装置の市場のエンドユーザー別内訳は？
• アテレクトミー装置の市場の世界における主要地域は？
• アテレクトミー装置の市場の世界における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界のアテレクトミー装置市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品別

• 方向性アテレクトミー装置
• 眼窩アテレクトミー装置
• 光アブレーションアテレクトミー装置
• 回転式アテレクトミー装置
• サポート装置

第7章 市場内訳：用途別

• 末梢血管
• 心臓血管
• 神経血管

第8章 市場内訳：エンドユーザー別

• 病院
• 外来手術センター
• 研究所と学術機関

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories
  • Avinger
  • B. Braun Melsungen AG
  • Biomerics
  • Biotronik
  • Boston Scientific Corporation
  • C.R. Bard（Becton, Dickinson and Company）
  • Cardinal Health Inc.
  • Koninklijke Philips N.V.
  • Medtronic
  • Minnetronix Inc.
  • Straub Medical AG（Becton, Dickinson and Company）
  • Terumo Corporation

List of Figures

• Figure 1: Global: Atherectomy Devices Market: Major Drivers and Challenges
• Figure 2: Global: Atherectomy Devices Market: Sales Value (in Million US$), 2018-2023
• Figure 3: Global: Atherectomy Devices Market: Breakup by Product (in %), 2023
• Figure 4: Global: Atherectomy Devices Market: Breakup by Application (in %), 2023
• Figure 5: Global: Atherectomy Devices Market: Breakup by End User (in %), 2023
• Figure 6: Global: Atherectomy Devices Market: Breakup by Region (in %), 2023
• Figure 7: Global: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 8: Global: Atherectomy Devices (Directional Atherectomy Devices) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 9: Global: Atherectomy Devices (Directional Atherectomy Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 10: Global: Atherectomy Devices (Orbital Atherectomy Devices) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 11: Global: Atherectomy Devices (Orbital Atherectomy Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 12: Global: Atherectomy Devices (Photo-Ablative Atherectomy Devices) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 13: Global: Atherectomy Devices (Photo-Ablative Atherectomy Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 14: Global: Atherectomy Devices (Rotational Atherectomy Devices) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 15: Global: Atherectomy Devices (Rotational Atherectomy Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 16: Global: Atherectomy Devices (Support Devices) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 17: Global: Atherectomy Devices (Support Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 18: Global: Atherectomy Devices (Peripheral Vascular) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 19: Global: Atherectomy Devices (Peripheral Vascular) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 20: Global: Atherectomy Devices (Cardiovascular) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: Atherectomy Devices (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 22: Global: Atherectomy Devices (Neurovascular) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 23: Global: Atherectomy Devices (Neurovascular) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 24: Global: Atherectomy Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 25: Global: Atherectomy Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 26: Global: Atherectomy Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 27: Global: Atherectomy Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 28: Global: Atherectomy Devices (Research Laboratories and Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 29: Global: Atherectomy Devices (Research Laboratories and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 30: North America: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 31: North America: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 32: United States: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 33: United States: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 34: Canada: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 35: Canada: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 36: Asia Pacific: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 37: Asia Pacific: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 38: China: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 39: China: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 40: Japan: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 41: Japan: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 42: India: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 43: India: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 44: South Korea: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 45: South Korea: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 46: Australia: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 47: Australia: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 48: Indonesia: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 49: Indonesia: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 50: Others: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 51: Others: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 52: Europe: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 53: Europe: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 54: Germany: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 55: Germany: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 56: France: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 57: France: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 58: United Kingdom: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 59: United Kingdom: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 60: Italy: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 61: Italy: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 62: Spain: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 63: Spain: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 64: Russia: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 65: Russia: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 66: Others: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 67: Others: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 68: Latin America: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 69: Latin America: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 70: Brazil: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 71: Brazil: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 72: Mexico: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 73: Mexico: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 74: Others: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 75: Others: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 76: Middle East and Africa: Atherectomy Devices Market: Sales Value (in Million US$), 2018 & 2023
• Figure 77: Middle East and Africa: Atherectomy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 78: Global: Atherectomy Devices Industry: SWOT Analysis
• Figure 79: Global: Atherectomy Devices Industry: Value Chain Analysis
• Figure 80: Global: Atherectomy Devices Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Atherectomy Devices Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Atherectomy Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
• Table 3: Global: Atherectomy Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 4: Global: Atherectomy Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
• Table 5: Global: Atherectomy Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 6: Global: Atherectomy Devices Market: Competitive Structure
• Table 7: Global: Atherectomy Devices Market: Key Players

The global atherectomy devices market size reached US$ 978.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,476.0 Million by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032. The rise in peripheral artery disease (PAD), significant technological advancements, rising ageing population, advent of minimally invasive surgeries, development of healthcare infrastructure, and reimbursement policies in emerging economies represent some of the key factors driving the growth of the atherectomy market.

Atherectomy Devices Market Analysis:

Major Market Drivers: The atherectomy devices market is affected by the increasing cases of peripheral artery disease (PAD) and other cardiovascular diseases. The rising ageing population that is more susceptible to these ailments, along with the rising instances of diabetes, obesity, and smoking, are creating an indirect demand for these devices. Moreover, technological advancements in atherectomy procedures and the growing popularity of minimally invasive surgeries are providing the market with substantial opportunities.

Key Market Trends: The atherectomy devices market is expanding mostly due to significant trends like the increasing cases of PAD and the requirement for minimally invasive surgeries. Advancements in technology enable the production of more advanced devices, which, in turn, give better accuracy and shorter recovery periods. Directional atherectomy systems are also rising in popularity since they allow the user to target and remove atherosclerotic plaque without damaging the vessel wall. In emerging economies, the growth of healthcare infrastructure and better reimbursement situations are propelling atherectomy device availability and usage worldwide.

Competitive Landscape: Some of the major market players in the Atherectomy Devices industry include Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company), Terumo Corporation, among many others.

Challenges and Opportunities: The atherectomy devices market suffers from several challenges, including high device costs and tough regulatory requirements that cause delays in product launches. On the contrary, market opportunities are also influenced by the growing incidence of peripheral artery diseases and aging population, which lead to the need for efficacious treatment alternatives. Developments in technology which improve the performance and safety of device provide growth opportunity. In addition, the growth of healthcare infrastructure in the emerging markets creates new fronts of market expansion, which stimulates the worldwide demand for atherectomy procedures.

Atherectomy Devices Market Trends:

Rising Cases of Peripheral Artery Disease (PAD)

The increasing cases of PAD at a global level due to ageing population and the rise in diabetes and obesity is leading the atherectomy device market growth. Approximately, PAD affects 8 to 12 million people in the United States, especially in those over 50. Out of these, 6.5 million over the age of 40 are diagnosed with PAD. Atherectomy devices provide a minimally invasive approach to remove arterial plaque as it is an important alternative in vascular interventions. The device enhances blood flow and reduces symptoms such as leg pain and fatigue. By directly cutting away or vaporizing the plaque, these devices help restore arterial patency, significantly improving patient outcomes in individuals with severe forms of PAD.

Technological Advancements

Major atherectomy devices innovations include the appearance of directionally controlled devices and high-frequency rotational technologies, which have continued to improve the effectiveness and safety of these devices. For instance, a 2020 study suggests that orbital atherectomy (which sands down plaque) effectively opens up blocked leg arteries 90 percent of the time, while laser atherectomy achieves similarly improved blood flow 76 percent of the time. These improvements in patient outcome and surgeon preference for these devices are propelling the growth of the atherectomy devices. In a multicenter study of 172 patients, Jetstream use had a 99% device success, and six-month and 12-month clinically-driven, target-lesion revascularization rates of 15% and 26%, respectively; with a one-year restenosis rate of 38% based on duplex imaging.

Expansion into Emerging Markets

Prominent key players are focusing on emerging economies where healthcare infrastructure development and growing healthcare spending is focused, thereby creating new opportunities for the key players in the market. For instance, the emerging markets of Brazil, Russia, India, China, and South Africa (BRICS) are increasingly shaping the landscape of the global health sector demand and supply for medical goods and services. Health spending as a percentage of GDP in 2030 is projected as - Brazil, 8.4%; Russia, 5.2%; India, 3.5%; China, 5.9%; South Africa, 10.4%. The penetration into these markets is enabled by realization of more advanced treatment alternatives, thus expanding the global footprint of atherectomy devices.

Atherectomy Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on product, application, and end user.

Breakup by Product:

Directional Atherectomy Devices

Orbital Atherectomy Devices

Photo-Ablative Atherectomy Devices

Rotational Atherectomy Devices

Support Devices

Directional Atherectomy Devices accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and support devices. According to the report, directional atherectomy devices represented the largest segment.

Directional atherectomy devices are created to precisely eliminate atherosclerotic plaque from obstructed arteries. These instruments provide the possibility of accurate control, which reduces vessel wall trauma, an important aspect for patient safety and recovery. Their ability to treat complex lesions in multiple vessel sizes makes them to be favoured by vascular specialists leading to the growth of the product segment. The capability of the devices to collect and remove plaque during the procedure sets these devices apart and is in a number of clinical situations preferable.

Breakup by Application:

Peripheral Vascular

Cardiovascular

Neurovascular

Peripheral Vascular accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes peripheral vascular, cardiovascular, and neurovascular. According to the report, peripheral vascular represented the largest segment.

The use of atherectomy devices in the treatment of peripheral vascular diseases is important because of the growing prevalence of PAD. Such devices play a key role in reestablishing the blood flow in leg arteries thus help to relieve the symptoms such as pain and mobility problems. The demand in this segment is determined by minimally invasive character of the procedure which allows short recovery period and lower risks of complications in comparison to conventional surgery making patient outcomes and treatment efficiencies higher.

Breakup by End User:

Hospitals

Ambulatory Surgery Centers

Research Laboratories and Academic Institutes

Hospitals accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgery centers, and research laboratories and academic institutes. According to the report, hospitals represented the largest segment.

Hospitals are the main users of atherectomy devices because these procedures are very complex and need advanced infrastructure and highly trained healthcare professionals. The growth of the segment is followed by the growth of the number of vascular surgeries conducted in hospitals, fueled by investments into advanced technologies and in the training programs of health providers. Ability of hospitals to offer all types of care including post-operative requirements also helps in making them the dominant subject in the market.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America dominates the market

The report has also provided a comprehensive analysis of all the major markets which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others), and Middle East and Africa. According to the report, North America was the largest market for atherectomy devices.

North America is the largest market for atherectomy because of high prevalence of cardiovascular diseases, developed healthcare system and the key market players in the region. The United States is the biggest market in this region because of the favourable reimbursement scenarios, clinical trials, and solid governmental support for research and development in advanced medical devices. The commitment of the region to application of new healthcare solutions is driving the market growth.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have been provided. Some of the major market players in the atherectomy devices market include Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company), and Terumo Corporation.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

There is a dynamic market in atherectomy devices with the use of evolving strategies by major players in pursuit to grow their market share and to satisfy the increasing demand for minimally invasive surgery alternatives. One of these approaches is technical oriented, which is to say that the companies invest significantly in R&D to improve their devices that become therefore more efficient and safer. The second common event is strategic alliances and collaborations that support knowledge sharing and better distribution channels. In addition, mergers and acquisitions are common enabling companies to expand their product portfolios and geographical coverage. Approvals by regulatory bodies play an important role here as the companies are trying to meet tough norms that guarantee the efficiency and safety of their products in many markets.

Atherectomy Devices Market News:

In March 2022, B. Braun acquired Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates.

In November 2023, Cardinal Health announced the U.S. launch of its SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room.

Key Questions Answered in This Report

• 1. What was the size of the global atherectomy devices market in 2023?
• 2. What is the expected growth rate of the global atherectomy devices market during 2024-2032?
• 3. What has been the impact of COVID-19 on the global atherectomy devices market?
• 4. What are the key factors driving the global atherectomy devices market?
• 5. What is the breakup of the global atherectomy devices market based on the product?
• 6. What is the breakup of the global atherectomy devices market based on the application?
• 7. What is the breakup of the global atherectomy devices market based on the end user?
• 8. What are the key regions in the global atherectomy devices market?
• 9. Who are the key players/companies in the global atherectomy devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Atherectomy Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Directional Atherectomy Devices
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Orbital Atherectomy Devices
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Photo-Ablative Atherectomy Devices
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Rotational Atherectomy Devices
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Support Devices
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Application

• 7.1 Peripheral Vascular
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Cardiovascular
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Neurovascular
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgery Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Research Laboratories and Academic Institutes
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott Laboratories
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Avinger
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
  • 14.3.3 B. Braun Melsungen AG
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Biomerics
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Biotronik
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Boston Scientific Corporation
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 C.R. Bard (Becton, Dickinson and Company)
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Cardinal Health Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Koninklijke Philips N.V.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Medtronic
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Minnetronix Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Straub Medical AG (Becton, Dickinson and Company)
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
  • 14.3.13 Terumo Corporation
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 Financials
    • 14.3.13.4 SWOT Analysis